日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy

多组学分析定义了尿路上皮癌的三种不同的分子亚型,这对精准治疗具有重要意义。

van Creij, Nils C H; Tymoszuk, Piotr; Handle, Florian; Seeber, Andreas; Sellemond, Teresa; Martowicz, Agnieszka; Comperat, Eva; Wafa, Hamed; Ormanns, Steffen; Günther, Michael; Parson, Walther; Noeparast, Maxim; Santer, Frédéric R; Subiela, José Daniel; Grivas, Petros; Li, Roger; Culig, Zoran; Pichler, Renate

Dysregulation of microRNAs and Centromere Protein Genes in Prostate Cancer and Metastatic Progression

前列腺癌中microRNA和着丝粒蛋白基因的失调及其在转移进展中的作用

Comuzzi, Barbara; Lambrinidis, Leonidas; Rogatsch, Hermann; Godoy-Tundidor, Sonia; Knezevic, Nikola; Krhen, Ivan; Marekovic, Zvonimir; Bartsch, Georg; Klocker, Helmut; Hobisch, Alfred; Culig, Zoran; Somuncu, Makbule Nihan; Karalezli, İlknur; Göger, Yunus Emre; Zamani, Ayşe Gül; Yıldırım, Mahmut Selman; Deveci, Asuman; Avunduk, Mustafa Cihat; Karalezli, Giray

Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells

原发性前列腺癌肿瘤中预先存在的细胞亚群显示出多西他赛耐药细胞的表面特征。

Drápela, Stanislav; Kvokačková, Barbora; Slabáková, Eva; Kotrbová, Anna; Gömöryová, Kristína; Fedr, Radek; Kurfürstová, Daniela; Eliáš, Martin; Študent, Vladimír Jr; Lenčéšová, Frederika; Ranjani, Ganji Sri; Pospíchalová, Vendula; Bryja, Vítězslav; van Weerden, Wytske M; Puhr, Martin; Culig, Zoran; Bouchal, Jan; Souček, Karel

The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer

微RNA miR-454和介导复合物组分MED12是前列腺癌中雄激素受体通路的重要调控因子。

Guzman, Juan; Hart, Martin; Weigelt, Katrin; Neumann, Angela; Aigner, Achim; Andolfi, Chiara; Handle, Florian; Rheinheimer, Stefanie; Fischer, Ulrike; Immel, Uta D; Lieb, Verena; Meese, Eckart; Culig, Zoran; Wullich, Bernd; Taubert, Helge; Wach, Sven

Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report

帕博利珠单抗联合奥拉帕尼治疗高肿瘤突变负荷(TMB)的顺铂难治性睾丸癌患者:首例病例报告

van Creij, Nils C H; Klinglmair, Gerald; Gruber, Leonhard; Partl, Antonia; Zeimet, Alain G; Santer, Frédéric R; Schnaiter, Simon; Mayr, Roman; Lackner, Felizian; Culig, Zoran; Seeber, Andreas; Pichler, Renate

Repurposing Amiodarone for Bladder Cancer Treatment.

将胺碘酮用于膀胱癌治疗

Roa Francisco J, Roubelakis Maria, Paschidis Konstantinos, van Creij Nils C H, Handle Florian, Makridakis Manousos, Narayanasamy Shaman, Balaur Irina-Afrodita, Tserga Aggeliki, Vlahou Antonia, Santer Frédéric R, Holm Per-Sonne, Hoffmann Michele, Puhr Martin, Mokou Marika, Frantzi Maria, Schneider Reinhard, Latosinska Agnieszka, Mischak Harald, Satagopam Venkata, Culig Zoran, Pichler Renate

Biological and therapeutic implications of sex hormone-related gene clustering in testicular cancer

性激素相关基因簇在睾丸癌中的生物学和治疗意义

Törzsök, Péter; Santer, Frédéric R; Kunz, Yannic; van Creij, Nils C H; Tymoszuk, Piotr; Klinglmair, Gerald; Culig, Zoran; Pichler, Renate

Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes

泌尿系统癌症的遗传和家族特征及其潜在基因

Hemminki, Kari; Kiemeney, Lambertus A; Morgans, Alicia K; Ranniko, Antti; Pichler, Renate; Hemminki, Otto; Culig, Zoran; Mulders, Peter; Bangma, Chris H

Androgen Receptor-Interacting Proteins in Prostate Cancer Development and Therapy Resistance

雄激素受体相互作用蛋白在前列腺癌发生发展和治疗耐药性中的作用

Culig, Zoran; Puhr, Martin

Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer.

抑制甾醇调节元件结合蛋白 SREBF-1 可克服晚期前列腺癌的多西他赛耐药性

Brandt Maximilian P, Vakhrusheva Olesya, Hackl Hubert, Daher Tamas, Tagscherer Katrin, Roth Wilfried, Tsaur Igor, Handle Florian, Eigentler Andrea, Culig Zoran, Thomas Christian, Erb Holger H H, Haferkamp Axel, Jüngel Eva, Puhr Martin